BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15696696)

  • 1. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transient inflammatory reaction in the lung after experimental hemorrhagic shock and resuscitation with a hemoglobin-vesicles solution compared with rat RBC transfusion.
    Yamanashi Y; Mori M; Terajima K; Tsueshita T; Horinouchi H; Sakai H; Sakamoto A
    ASAIO J; 2009; 55(5):478-83. PubMed ID: 19625952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions.
    Sakai H; Sato A; Takeoka S; Tsuchida E
    Langmuir; 2007 Jul; 23(15):8121-8. PubMed ID: 17567054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid resuscitation with hemoglobin vesicles in a rabbit model of acute hemorrhagic shock.
    Terajima K; Tsueshita T; Sakamoto A; Ogawa R
    Shock; 2006 Feb; 25(2):184-9. PubMed ID: 16525358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress and trend in the development of artificial blood].
    Tsuchida E
    Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic carriers of oxygen.
    Dellacherie E; Labrude P; Vigneron C; Riess JG
    Crit Rev Ther Drug Carrier Syst; 1987; 3(1):41-94. PubMed ID: 3542244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human serum albumin incorporating synthetic heme: red blood cell substitute without hypertension by nitric oxide scavenging.
    Tsuchida E; Komatsu T; Matsukawa Y; Nakagawa A; Sakai H; Kobayashi K; Suematsu M
    J Biomed Mater Res A; 2003 Feb; 64(2):257-61. PubMed ID: 12522812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell substitutes from hemoglobin--do we start all over again?
    Kluger R
    Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange transfusion with entirely synthetic red-cell substitute albumin-heme into rats: physiological responses and blood biochemical tests.
    Huang Y; Komatsu T; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
    J Biomed Mater Res A; 2004 Oct; 71(1):63-9. PubMed ID: 15368255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin-vesicles as a transfusion alternative.
    Tsuchida E; Sakai H; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):581-8. PubMed ID: 17090430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?
    Alayash AI
    Nat Biotechnol; 1999 Jun; 17(6):545-9. PubMed ID: 10385317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin-vesicles as an artificial oxygen carrier.
    Sakai H; Sou K; Tsuchida E
    Methods Enzymol; 2009; 465():363-84. PubMed ID: 19913177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated albumin-heme as an oxygen-carrying plasma expander: Exchange transfusion into acute anemia rat model.
    Huang Y; Komatsu T; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
    Biomaterials; 2006 Sep; 27(25):4477-83. PubMed ID: 16678256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats.
    Sakai H; Masada Y; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
    Crit Care Med; 2004 Feb; 32(2):539-45. PubMed ID: 14758176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
    Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
    Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.